Gastro Esophageal Junction Cancer Active Not Recruiting Phase 2 Trials for Afatinib (DB08916)

Also known as: Gastroesophageal-junction Cancer / Gastroesophageal Junction Cancer / Gastro-oesophageal Junction Cancer / Gastro-esophageal Junction Cancer / Gastrooesophageal junction cancer / Carcinoma of oesophagus NOS / Carcinoma of oesophagus / Carcinoma of esophagus (disorder) / Carcinoma of esophagus / Oesophageal carcinoma NOS / Oesophageal carcinoma / Esophageal carcinoma NOS / Esophageal carcinoma / Primary malignant neoplasm of esophagus (disorder)

IndicationStatusPhase
DBCOND0106887 (Gastro Esophageal Junction Cancer)Active Not Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02501603Afatinib, Paclitaxel, 2nd Line, Advanced Gastric CancerTreatment